LU-001i is a selective inhibitor of the proteasome β1i subunit (LMP2). While LU-001i exhibits minimal immunomodulatory effects as a standalone treatment, its combination with LMP7 inhibitors, such as PRN1126, enhances anti-inflammatory and immunomodulatory activities. This reagent is valuable for investigating the mechanisms underlying autoimmune diseases and developing targeted therapeutic strategies.
LU-001i is a selective inhibitor of the proteasome β1i subunit (LMP2). While LU-001i exhibits minimal immunomodulatory effects as a standalone treatment, its combination with LMP7 inhibitors, such as PRN1126, enhances anti-inflammatory and immunomodulatory activities. This reagent is valuable for investigating the mechanisms underlying autoimmune diseases and developing targeted therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
